High-Dose Alkylating Agent Therapy: A Review of Clinical Experiences

This publication has 27 references indexed in Scilit:

• Cisplatin, adriamycin, and etoposide (cav) for remission induction of small-cell bronchogenic carcinoma. Evaluation of efficacy and toxicity and pilot study of a “late intensification” with autologous bone-marrow rescue
  Cancer, 1982
• Limitations of High Dose Intra-arterial 1,3-Bis(2-chloroethyl)-1-nitrosourea (BCNU) Chemotherapy for Malignant Gliomas
  Neurosurgery, 1982
• High-dose BCNU with autologous bone marrow rescue for recurrent glioblastoma multiforme
  Journal of Neurosurgery, 1981
• Hochdosierte Mustargen-Therapie (HN2) mit autologer Knochenmarks-transplantation bei fortgeschrittenem malignem Melanom
  Annals of Hematology, 1981
• Cyclophosphamide pretreatment reduces the toxic effect of high dose melphalan on intestinal epithelium in sheep
  Published by Elsevier ,1978
• ACCELERATION OF BONE-MARROW RECOVERY BY PRE-TREATMENT WITH CYCLOPHOSPHAMIDE IN PATIENTS RECEIVING HIGH-DOSE MELPHALAN
  The Lancet, 1978
• Remission Induction in Chronic Granulocytic Leukaemia using Intermittent High-Dose Busulphan
  British Journal of Haematology, 1978
• The Evolution of Therapeutic Research in Cancer
  New England Journal of Medicine, 1978
• The treatment of advanced ovarian carcinoma with high dose, intravenous cyclophosphamide
  Gynecologic Oncology, 1976
• Chemotherapy of advanced ovarian carcinoma: A prospective randomized comparison of phenylalanine mustard and high dose cyclophosphamide
  Gynecologic Oncology, 1974